BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

BioCardia, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.90−0.02 (-2.46%)

Close on Oct 19, 2026

Market cap: $10.85M
P/E (TTM): –
Dividend yield: –

BioCardia, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	2.50	2.37	1.10	7.36	13	21	5.59	5.36	13	21	3.56	3.18	13	13	13	0.13	4.97
Cash & Short-Term Investments	2.50	2.37	1.10	7.36	13	21	5.59	5.36	13	21	3.56	3.18	13	13	13	0.13	4.97
Receivables	0.02	0	0.06	0.20	0.15	0.23	0.15	0.27	0.10	0.07	0.11	–	–	0	0.07	0.41	–
Inventory	–	–	–	–	–	–	0.00	0.14	0.19	0.14	0.76	–	–	–	–	–	–
Prepaid Expenses & Other	0.22	0.25	0.30	0.30	0.46	0.40	–	0.45	0.34	0.36	0.15	0.04	0.04	0.03	0.09	0.10	–
Total Current Assets	2.73	2.62	1.46	7.86	13	23	6.38	6.22	13	22	4.67	–	–	13	14	0.64	–
Property, Plant & Equipment	0.02	0.03	0.09	0.17	0.18	0.15	0.18	0.15	0.17	0.11	0.15	–	–	–	–	–	–
Gross Property, Plant & Equipment	0.80	0.79	0.79	0.79	0.72	1.17	1.14	0.99	0.93	0.88	0.88	–	–	–	–	–	–
Accumulated Depreciation	-0.79	-0.76	-0.69	-0.62	-0.54	-1.03	-0.96	-0.85	-0.76	-0.77	-0.73	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	0.49	0.90	1.26	1.59	1.88	0.57	1.07	1.51	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	0.17	0.17	0.17	0.17	0.17	0.05	0.05	0.05	0.05	0.05	0.04	–	–	–	–	–	–
Total Assets	3.41	3.72	2.99	9.79	16	23	7.68	6.42	14	22	4.86	14	14	13	14	5.44	–
Accounts Payable	0.64	0.39	0.89	0.68	0.51	0.75	0.91	0.74	0.90	0.53	0.54	0.01	0.00	0.01	0.13	1.66	–
Accrued Expenses	0.03	0.02	0.08	0.16	0.24	0.09	0.01	0.13	0.47	0.48	0.69	–	–	–	–	–	–
Current Portion of Leases	0.44	0.39	0.33	0.32	0.24	0.61	0.53	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.56	–	–
Deferred Revenue (Current)	–	–	0	0.34	0.85	0.68	0.10	0.11	0.06	0.07	0.04	–	–	–	–	–	–
Total Current Liabilities	2.43	2.32	3.61	3.59	3.71	4.25	4.00	2.55	2.33	1.44	8.30	–	–	–	–	–	–
Long-Term Leases	0.09	0.57	0.98	1.32	1.63	0	0.61	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.53	0.95	1.32	1.63	1.87	0.61	1.14	1.59	–	–	–	–	–	–	–	–	–
Total Liabilities	2.52	2.89	4.59	4.90	5.34	4.25	5.31	2.63	2.41	1.50	8.30	0.01	0.00	0.01	0.76	2.16	–
Preferred Stock	0	0	0	0	0	0	–	–	0	0	–	–	–	–	–	–	–
Common Stock	0.01	0.01	0.00	0.02	0.02	0.02	0.01	0.01	0.04	0.04	0.02	0.23	0.23	0.23	0.23	0.23	–
Additional Paid-In Capital	169	161	151	145	139	135	103	90	84	81	0.34	26	26	26	26	26	–
Retained Earnings	-168	-160	-152	-141	-129	-116	-101	-86	-72	-60	-50	-12	-12	-13	-13	-23	–
Shareholders' Equity	0.90	0.84	-1.60	4.89	10	19	2.37	3.79	11	21	-3.44	-43	13	13	13	3.28	15
Total Equity	0.90	0.84	-1.60	4.89	10	19	2.37	3.79	11	21	-3.44	-43	13	13	13	3.28	15
Total Liabilities & Equity	3.41	3.72	2.99	9.79	16	23	7.68	6.42	14	22	4.86	14	14	13	14	5.44	–
Shares Outstanding(shares)	11	4.60	1.58	20	17	16	6.83	4.85	4.25	4.24	2.11	2.07	2.07	2.07	2.07	2.07	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -950.1%

Financial strength

Current ratio: 2.09
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 200.3%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 4.02
Dividend yield: –